Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

177.81
BATS BZX Real-Time Price
As of 1:23pm ET
 -3.17 / -1.75%
Today’s Change
127.10
Today|||52-Week Range
196.47
-7.36%
Year-to-Date

Today’s Trading

Previous close180.98
Today’s open181.15
Day’s range177.27 - 181.15
Volume37,078
Average volume (3 months)1,069,476
Market cap$26.5B
Dividend yield--
Data as of 1:23pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)+30.80%
Earnings growth (this year)+6.31%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+19.25%
P/E ratio61.0
Price/Sales12.89
Price/Book14.35

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-1.40-2.72%
TECHBio-Techne Corp-0.06-0.06%
JUNOJuno Therapeutics In...-0.77-2.46%
XONIntrexon Corp-0.45-1.62%
Data as of 1:23pm ET, 09/29/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$0.91
Annual revenue (last year)$2.2B
Annual profit (last year)$461.6M
Net profit margin20.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Senior Vice President-Global Quality &
Operations
Robert P. Ragusa
Corporate headquarters
San Diego, California

Forecasts

Search for Jobs